page_banner

3415-08-5 L-Tyr-NCA

3415-08-5 L-Tyr-NCA

Description:

Aspectus White ad Off-White crystallis seu crystallinum pulveris
MF C10H9NO4
MW 207.18
Puritas 98+


Product Detail

Transportatio conditio & commendatur naviculas modum:
per aerem, per mare vel per express

Repono conditione:
nert atmosphaera, Store in freezer, sub -20° C*

Ordinis Qty minimum:
Negatio

Certification:
COA, HPLC, GC, HNMR, Assay, Aqua Content (KF), TLC available

D-Lys(tfa)-NCA (2)

Synonyma

Tyrosine, NCA;

N-Carboxy-L-tyrosine anhydride;

(4S)-4-[(4-Hydroxyphenyl)methyl]-2,5-oxazolidinedione;

L-Tyrosine N-carboxyanhydride;

(2,5-Oxazolidinedione,4-[(4-hydroxyphenyl)Methyl]-, (4S)-;

N-Carbonyl-L-Tyrosine Anhydride

interiorem sarcina

Solent ad stipant pulveris.Et solem et aquam possunt prohibere mala questus.

Interiorem sarcina 2
Interiorem sarcina 1
Interiorem sarcina III "

exteriores sarcina

Lobortis duris res tuas ex fragore et umore questus protegere potest.

Exterior sarcina III "
Exterior sarcina II "
Exterior sarcina 1

Applications

3415-08-5 L-Tyr-NCA est una intermedia Glatirameri Acetate.

Acetate glatiramer est agens peptidium synthetice compositum ex amino acidis quattuor: acidum glutamicum, alaninum, tyrosinum et lysinum.Prima eius applicatio in curatione Sclerosis Multiplicis (MS), inveterata, inflammatoria, demyelinantis morborum systematis nervosi centrali afficiens.Per mechanismum "obpressionis bypass" Glatiramer acetate immunomodulatorium et anti-inflammatorium effectum in MS exercet, augens gradus factoris neurotrophici cerebri derivati ​​(BDNF), inflammatio deflexa demyelinationem inducta et incrementum axonum et vaginarum myelini augens.

Globally, Glatiramer Acetate late patet.Exempli gratia, in Civitatibus Foederatis, sub nomine Copaxone notae venales sunt et a Cibus et Drug Administration (FDA) ad curationem Sclerosis Multiplices approbata est.In regionibus occidentalibus cum magna rerum MS praevalentia, eius efficacia et tolerabilitas divulgata sunt.

In Sinis, die 28 Iunii 2023, "Glatiramer Iniectio acetatis" publice approbavit e Nationalibus Medical Products Administration (NMPA) ad curationem aegrorum adultorum remisso-remittentes Multiplex Sclerosis (MS), inclusa syndrome cinematico solitario, relapso-remisso. MS, activum secun- tivum, MS.

Related Products

L-Gly-NCA L-Ala-NCA D-Ala-NCA L-Val-NCA
D-Leu-NCA DL-leu-NCA L-Phe-NCA D-Tyr-NCA
L-Tyr(bzl)-NCA L-Glu(Obzl)-NCA D-Asp(OBzl)-NCA L-Lys(tfa)-NCA
L-Lys(Cbz)-NCA D-Lys(Cbz)-NCA Sar-NCA

Superioritas

1. R & D ministerium praesto
2. ISO fabrica certificata, cautio qualitatis
3.A plena curriculum sequitur opera per productionem
4.High sumptus efficens
5.Quality documenta certificatione provisum est per petitionem elit
6.Great post-venditio muneris arctam necessitudinem cum mos conservans
7.Full resource ad auxilium decrescentes shipping costs
8.Free specimen oblatum Lorem species prior ad mercedem
9.Payment terminus agi
10.Assit customers res in Sina


  • Priora:
  • Deinde:

  • Epistulam tuam hic scribe et mitte nobis